A 39-year-old woman was admitted with dysarthria, left facio-brachio-crural paresis, and increased frontotemporal headache. She had undergone heart transplantation due to end-stage Chagas heart disease 4 months previously and was on immunosuppression therapy. MRI of the brain demonstrated a right cortico-subcortical frontoparietal lesion with mass effect and heterogeneous enhancement with gadolinium (figure 1). Stereotaxic brain biopsy demonstrated nests of amastigotes and assay for Trypanosoma cruzi confirmed the diagnosis (figure 2).
Figure 1 MRI reveals a right frontotemporal tumor-like lesion
Lesion is (A) hyperintense in T2 and (B) hypointense in T1 with heterogeneous enhancement after gadolinium injection. Author contributions: Sarah Camargos: study concept, design, acquisition of data, study supervision. Maria da Consolação Vieira Moreira: study concept, design, critical revision of the manuscript for important intellectual content. Denise Maria Meneses Cury Portela: analysis and interpretation of the data. João Paulo Imperes Lira: analysis and interpretation of the data. Fabio Valério Santos Modesto: analysis and interpretation of the data. Guilherme Marques Miranda Menezes: analysis and interpretation of the data. Daniel Ribeiro Moreira: analysis and interpretation of the data. 
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